Cisplatin plus gemcytabine versus cisplatin plus vinorelbine in patients with stage IV nonsmall cell lung cancer (NSCLC): Results of single center experience
JavaScript is disabled for your browser. Some features of this site may not work without it.
Cisplatin plus gemcytabine versus cisplatin plus vinorelbine in patients with stage IV nonsmall cell lung cancer (NSCLC): Results of single center experience